Skip to main content
SpringerLink
Log in

Lymphocyte inhibition is compromised in mesenchymal stem cells from psoriatic skin

  • Investigative Report
  • Published:
European Journal of Dermatology

Abstract

Background

Psoriasis is a chronic inflammatory skin disorder associated with a host of immune abnormalities. Mesenchymal stem cells (MSCs) have immunosuppressive properties and, in earlier studies, we found that the bone marrow MSCs of patients with psoriasis exhibit abnormal cytokine secretion. Since MSCs can be isolated from skin, we hypothesized that the biological characteristics of MSCs in psoriatic skin lesions might reflect the pathogenesis of psoriasis.

Objective

To investigate the effects of MSCs from psoriatic skin lesions on T-cell proliferation.

Materials and Methods

MSCs obtained from psoriatic skin lesions and healthy human skin were examined by flow cytometry and cell differentiation assays. MSCs were co-cultured with normal peripheral blood T cells to assess changes in T-cell proliferation. Concentrations of interleukin (IL)-6, IL-11, hepatocyte growth factor (HGF), and transforming growth factor (TGF)-β1 in the MSC culture supernatants were measured by enzyme-linked immunosorbent assays.

Results

Surface markers and differentiation capacity were similar in MSCs from both sources. MSCs in psoriatic skin lesions were weaker inhibitors of T-cell proliferation (p<0.05) and exhibited increased secretion of IL-11 and reduced secretion of IL-6 and HGF (p<0.05). Secretion of TGF-β1 was unchanged (p>0.05).

Conclusion

This study demonstrated abnormalities in MSCs derived from psoriatic skin lesions. We suggest that the attenuated inhibitory effect on T-cell proliferation might be one of the pathogenic mechanisms of psoriasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature 2007; 445(7130): 866–73.

    Article  CAS  PubMed  Google Scholar 

  2. Danilenko DM. Review paper: preclinical models of psoriasis. Vet Pathol 2008; 45(4): 563–75.

    Article  CAS  PubMed  Google Scholar 

  3. Krueger JG, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005; 64(Suppl 2): ii30–6.

    Google Scholar 

  4. Zhang K, Liu R, Yin G, et al. Differential cytokine secretion of cultured bone marrow stromal cells from patients with psoriasis and healthy volunteers. Eur J Dermatol 2010; 20: 49–53.

    CAS  PubMed  Google Scholar 

  5. Spaggiari GM, Abdelrazik H, Becchetti F, et al. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 2009; 113: 6576–83.

    Article  CAS  PubMed  Google Scholar 

  6. Spaggiari GM, Capobianco A, Becchetti S, et al. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006; 107: 1484–90

    Article  CAS  PubMed  Google Scholar 

  7. Esposito M, Lucariello A, Costanzo C, et al. Differentiation of human umbilical cord-derived mesenchymal stem cells, WJ-MSCs, into chondrogenic cells in the presence of pulsed electromagnetic fields. InVivo 2013; 27: 495–500.

    CAS  Google Scholar 

  8. Cutler AJ, Limbani V, Girdlestone J, et al. Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation. J Immunol 2010; 185: 6617–23.

    Article  CAS  PubMed  Google Scholar 

  9. In’t Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003; 102: 1548–9.

    Article  Google Scholar 

  10. Miao Z, Jin J, Chen L, et al. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol Int 2006; 30: 681–7.

    Article  CAS  PubMed  Google Scholar 

  11. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279–95.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Vaculik C, Schuster C, Bauer W, et al. Human dermis harbors distinct mesenchymal stromal cell subsets. J Invest Dermatol 2012; 132: 563–74.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Campanati A, Orciani M, Gorbi S, et al. Effect of biologic therapies targeting tumour necrosis factor- on cutaneous mesenchymal stem cells in psoriasis. Br J Dermatol 2012; 167: 68–76.

    Article  CAS  PubMed  Google Scholar 

  14. Orciani M, Gorbi S, Benedetti M, et al. Oxidative stress defense in human-skin-derived mesenchymal stem cells versus human keratinocytes: different mechanisms of protection and cell selection. Free Radic Biol Med 2010; 49: 830–8.

    Article  CAS  PubMed  Google Scholar 

  15. Salvolini E, Orciani M, Vignini A, et al. Skin-derived mesenchymal stem cells (S-MSCs) induce endothelial cell activation by paracrine mechanisms. Exp Dermatol 2010; 19: 848–50.

    Article  PubMed  Google Scholar 

  16. Gieseke F, Böhringer J, Bussolari R, et al. Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood 2010; 116: 3770–9.

    Article  CAS  PubMed  Google Scholar 

  17. Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838–43.

    Article  PubMed  Google Scholar 

  18. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008; 8: 726–36.

    Article  CAS  PubMed  Google Scholar 

  19. Laggner U, Di Meglio P, Perera GK, et al. Identification of a novel proinflammatory human skin-homing V9V2 T cell subset with a potential role in psoriasis. J Immunol 2011; 187: 2783–93.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Liu R, Yang Y, Yan X, et al. Abnormalities in cytokine secretion from mesenchymal stem cells in psoriatic skin lesions. Eur J Dermatol 2013; 23: 600–7.

    CAS  PubMed  Google Scholar 

  21. Yin G, Li X, Li J, et al. Screening of differentially expressed genes and predominant expression of variable region of T cell receptor in peripheral T cells of psoriatic patients. Eur J Dermatol 2011; 21: 938–44.

    CAS  PubMed  Google Scholar 

  22. Jääger K, Islam S, Zajac P, et al. RNA-seq analysis reveals different dynamics of differentiation of human dermis- and adipose-derived stromal stem cells. PLoS One 2012; 7: e38833.

    Article  Google Scholar 

  23. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315–7.

    Article  CAS  PubMed  Google Scholar 

  24. Elder JT, Bruce AT, Gudjonsson JE, et al. Molecular dissection of psoriasis: integrating genetics and biology. J Invest Dermatol 2010; 130: 1213–26.

    Article  CAS  PubMed  Google Scholar 

  25. Nograles KE, Davidovici B, Krueger JG. New insights in the immunologic basis of psoriasis. Semin Cutan Med Surg 2010; 29: 3–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Valdimarsson H, Baker BS, Jónsdóttir I, et al. Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 1995; 16: 145–9.

    Article  CAS  PubMed  Google Scholar 

  27. Wolf R, Mascia F, Dharamsi A, et al. Gene from a psoriasis susceptibility locus primes the skin for inflammation. Sci Transl Med 2010; 2: 61ra90.

    Article  CAS  PubMed  Google Scholar 

  28. Kastelan M, Massari LP, Pasic A, et al. New trends in the immunopathogenesis of psoriasis. Acta Dermatovenerol Croat 2004; 12: 26–9.

    PubMed  Google Scholar 

  29. Bata-Csorgo Z, Hammerberg C, Voorhees JJ, et al. Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia. J Invest Dermatol 1995; 105: 89S–94S.

    Article  CAS  PubMed  Google Scholar 

  30. Aldinucci A, Rizzetto L, Pieri L, et al. Inhibition of immune synapse by altered dendritic cell actin distribution: a new pathway of mesenchymal stem cell immune regulation. J Immunol 2010; 185: 5102–10.

    Article  CAS  PubMed  Google Scholar 

  31. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42–8.

    Article  PubMed  Google Scholar 

  32. Krampera M, Glennie S, Dyson J, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101: 3722–9.

    Article  CAS  PubMed  Google Scholar 

  33. Wang Y, Lewis DF, Gu Y, et al. Elevated maternal soluble Gp130 and IL-6 levels and reduced Gp130 and SOCS-3 expressions in women complicated with preeclampsia. Hypertension 2011; 57: 336–42.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. Diehl S, Rincón M. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 2002; 39: 531–6.

    Article  CAS  PubMed  Google Scholar 

  35. Atsumi T, Sato M, Kamimura D, et al. IFN-gamma expression in CD8+ T cells regulated by IL-6 signal is involved in superantigenmediated CD4+ T cell death. Int Immunol 2009; 21: 73–80.

    Article  CAS  PubMed  Google Scholar 

  36. Kawaguchi M, Fujita J, Kokubu F, et al. IL-17F-induced IL-11 release in bronchial epithelial cells via MSK1-CREB pathway. Am J Physiol Lung Cell Mol Physiol 2009; 296: L804–10.

    Article  Google Scholar 

  37. Curti A, Tafuri A, Ricciardi MR, et al. Interleukin-11 induces proliferation of human T-cells and its activity is associated with downregulation of p27(kip1). Haematologica 2002; 87: 373–80.

    CAS  PubMed  Google Scholar 

  38. Curti A, Ratta M, Corinti S, et al. Interleukin-11 induces Th2 polarization of human CD4(+) T cells. Blood 2001; 97: 2758–63.

    Article  CAS  PubMed  Google Scholar 

  39. Jain S, Kaur IR, Das S, et al. T helper 1 to T helper 2 shift in cytokine expression: an autoregulatory process in superantigen-associated psoriasis progression? J Med Microbiol 2009; 58: 180–4.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Dermatology, Taiyuan City Centre Hospital, No. 1 Dong San Dao Xiang, Taiyuan, Shanxi Province, 030009, China

    Ruifeng Liu, Xincheng Zhao, Yuanwen Yang & Kaiming Zhang

  2. Department of Dermatology, Qinghai University Affiliated Hospital, Xining, Qinghai Province, 810000, China

    Yong Wang

Authors
  1. Ruifeng Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xincheng Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuanwen Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kaiming Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kaiming Zhang.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, R., Wang, Y., Zhao, X. et al. Lymphocyte inhibition is compromised in mesenchymal stem cells from psoriatic skin. Eur J Dermatol 24, 560–567 (2014). https://doi.org/10.1684/ejd.2014.2394

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2014.2394

Key words

Search

Navigation